Utang marang nilai buku: twistbioscience.com (TWST)

Tandha merek Twist Bio (TWST)

The share price of Twist Bioscience (TWST) visualized below reflects the dynamics of a business striving for leadership in synthetic biology through silicon technologies and DNA data storage. Proprietary chips enable the company to reduce costs and set market standards for synthesis pricing. Despite strict US oversight of biotechnology exports, the asset remains stable, and the 0.21 metric confirms the issuer's current status.

TWST (Twist Bioscience Corp) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026
Produk merek Twist Bioscience Corp

Scaling DNA synthesis on silicon chips requires significant capital expenditures, making debt load control critical for Twist Bioscience (TWST). The total liabilities-to-net equity ratio, represented by the share of financial debt in the firm's book capitalization, allows investors to assess financial stability and bankruptcy risk while balancing safety against the efficiency of leverage.

Pesaing Twist Bioscience

Utang-utang marang kapitalisasi buku TEM (Tempus AI Inc)|QGEN - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Ionis IONS|Repligen Corp (RGEN) - Utang marang modal buku|RNA (Avidity) - Utang marang nilai buku|CRISPR (CRSP) - Utang marang nilai buku|WGS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik RARE|BEAM (Beam Therapeutics) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Sarepta Therapeutics SRPT|Utang marang nilai buku 10x Genomics Corp (TXG)|NTLA - Utang marang modal buku|Utang marang nilai buku Stoke Therapeutics (STOK)|BLFS - Rasio utang marang aset resik|Wave Life Sciences Ltd. (WVE) - Utang-utang marang kapitalisasi buku|Maze Therapeutics, Inc. (MAZE) - Rasio utang marang kapitalisasi buku|SION: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik PRME|Taysha Gene Therapies - Rasio utang marang kapitalisasi buku|Utang-utang marang nilai buku QURE (uniqure.com)|Rasio utang marang kapitalisasi buku MGTX|Utang-utang marang aset resik REGENXBIO Inc RGNX|SLDB: Utang-utang marang kapitalisasi buku|OCGN - Utang marang nilai buku|Pacific Biosciences - Utang-utang marang kapitalisasi buku|benitec.com (BNTC) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku DSGN (Design Therapeutics, Inc.)|Utang-utang marang nilai buku RCKT|Rasio utang marang kapitalisasi buku 4D Molecular Therapeutics Inc FDMT|Rasio utang marang nilai buku lexeotx.com (LXEO)|Korro Bio - Utang-utang marang kapitalisasi buku|Utang marang nilai buku editasmedicine.com EDIT|SLN (Silence Therapeutics plc) - Utang-utang marang kapitalisasi buku|ProQR Therapeutics N.V. (PRQR) - Utang-utang marang nilai buku|CDXS - Utang marang nilai buku|Utang marang modal buku Sangamo BioSciences|Utang marang nilai buku NAUT|Utang marang nilai buku MGX|DTIL (Precision BioSciences, Inc.) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik generationbio.com GBIO|Utang marang nilai buku Boundless Bio, Inc (BOLD)|Utang marang modal buku Exicure Inc. XCUR|Celsion Corporation (IMNN) - Utang-utang marang kapitalisasi buku|PHIO: Rasio utang marang nilai buku|Rasio utang marang kapitalisasi buku mustangbio.com|TransCode Therapeutics, Inc. (RNAZ) - Rasio utang marang nilai buku|BNGO (Bionano Genomics Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Applied DNA Corp (APDN)|Utang marang nilai buku bluebird bio, Inc.|Utang marang modal buku immunoprecise.com IPA|Omega Therapeutics, Inc. - Utang marang nilai buku|Utang marang nilai buku Singular Genomics Systems, Inc. OMIC|Utang-utang marang kapitalisasi buku RGLS (Regulus Therapeutics Inc)|SYRS: Utang-utang marang aset resik|Telesis Bio, Inc. - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik traconpharma.com|Unity Biotechnology, Inc. (UBX) - Utang marang nilai buku